Found: 15
Select item for more details and to access through your institution.
Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 3, p. 392, doi. 10.1093/neuonc/noy124
- By:
- Publication type:
- Article
randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 3, p. 348, doi. 10.1093/neuonc/noy200
- By:
- Publication type:
- Article
Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 3, p. 326, doi. 10.1093/neuonc/noy184
- By:
- Publication type:
- Article
Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005–2015, using the Central Brain Tumor Registry of the United States.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 3, p. 380, doi. 10.1093/neuonc/noy162
- By:
- Publication type:
- Article
Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 3, p. 360, doi. 10.1093/neuonc/noy195
- By:
- Publication type:
- Article
Introduction of novel agents in the treatment of primary CNS lymphoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 3, p. 306, doi. 10.1093/neuonc/noy193
- By:
- Publication type:
- Article
Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 3, p. 337, doi. 10.1093/neuonc/noy185
- By:
- Publication type:
- Article
Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 3, p. 314, doi. 10.1093/neuonc/noy177
- By:
- Publication type:
- Article
Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 3, p. 404, doi. 10.1093/neuonc/noy133
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 3, p. 293, doi. 10.1093/neuonc/noz020
- By:
- Publication type:
- Article
Glioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in Finland.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 3, p. 370, doi. 10.1093/neuonc/noy164
- By:
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 3, p. 415, doi. 10.1093/neuonc/noz019
- Publication type:
- Article
Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 3, p. 296, doi. 10.1093/neuonc/noy192
- By:
- Publication type:
- Article
Brain and central nervous system tumor statistics: access to accurate data for all countries is critical!
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 3, p. 291, doi. 10.1093/neuonc/noy205
- By:
- Publication type:
- Article
Bespoke immunotherapy: how close are we?
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 3, p. 289, doi. 10.1093/neuonc/noz017
- By:
- Publication type:
- Article